A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback